{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:58:10Z","timestamp":1792839490989,"version":"4.5.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jhepr.2023.100882","type":"journal-article","created":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T01:15:34Z","timestamp":1691889334000},"page":"100882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Management of liver disease and portal hypertension in common variable immunodeficiency (CVID)"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6400-9655","authenticated-orcid":false,"given":"Lukas S.","family":"Baumert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8945-5997","authenticated-orcid":false,"given":"Angela","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100882_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/cei.12178","article-title":"New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin","volume":"174","author":"Ameratunga","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib2","first-page":"302ra135","article-title":"IgH sequences in common variable immune deficiency reveal altered B cell development and selection","volume":"7","author":"Roskin","year":"2015"},{"key":"10.1016\/j.jhepr.2023.100882_bib3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2009.10.013","article-title":"International Union of Immunological Societies Expert Committee on Primary I. Primary immunodeficiencies: 2009 update","volume":"124","author":"Notarangelo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fimmu.2020.00338","article-title":"Heterogeneity of liver disease in common variable immunodeficiency disorders","volume":"11","author":"Pecoraro","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12026-018-8996-5","article-title":"Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes","volume":"66","author":"Modell","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.jhepr.2023.100882_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18176\/jiaci.0388","article-title":"Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management","volume":"30","author":"Yazdani","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01131.x","article-title":"Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)","volume":"120","author":"Hammarstrom","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10875-007-9103-1","article-title":"Population prevalence of diagnosed primary immunodeficiency diseases in the United States","volume":"27","author":"Boyle","year":"2007","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar4032","article-title":"Common variable immunodeficiency: an update","volume":"14","author":"Salzer","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jhepr.2023.100882_bib11","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3389\/fimmu.2020.00982","article-title":"Shorter diagnostic delay in polish adult patients with common variable immunodeficiency and symptom onset after 1999","volume":"11","author":"Zietkiewicz","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100882_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib14","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jhepr.2023.100882_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/cei.12661","article-title":"The Swiss national registry for primary immunodeficiencies: report on the first 6 years\u2019 activity from 2008 to 2014","volume":"182","author":"Marschall","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.18176\/jiaci.0166","article-title":"Infectious and noninfectious pulmonary complications in patients with primary immunodeficiency disorders","volume":"27","author":"Yazdani","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib17","first-page":"1263","article-title":"Development of cancer in patients with primary immunodeficiencies","volume":"28","author":"Salavoura","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jhepr.2023.100882_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1157\/13072916","article-title":"[Autoimmune disease in primary antibody deficiencies]","volume":"33","author":"Sarmiento","year":"2005","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jhepr.2023.100882_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11894-016-0491-3","article-title":"Gastrointestinal disorders associated with common variable immune deficiency (CVID) and chronic granulomatous disease (CGD)","volume":"18","author":"Uzzan","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jhepr.2023.100882_bib20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12016-017-8638-z","article-title":"Common variable immunodeficiency and liver involvement","volume":"55","author":"Song","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2017.03.011","article-title":"Delay in diagnosis affects the clinical outcome in a cohort of cvid patients with marked reduction of iga serum levels","volume":"180","author":"Graziano","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jhepr.2023.100882_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency","volume":"135","author":"Wehr","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib25","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2019.01.051","article-title":"Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies","volume":"144","author":"Milito","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.jhepr.2023.100882_bib26","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s10875-008-9182-7","article-title":"Autoimmune manifestations in common variable immunodeficiency","volume":"28","author":"Cunningham-Rundles","year":"2008","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib27","doi-asserted-by":"crossref","first-page":"933463","DOI":"10.3389\/fimmu.2022.933463","article-title":"Liver disease accompanied by enteropathy in common variable immunodeficiency: common pathophysiological mechanisms","volume":"13","author":"Lima","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib28","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3389\/fimmu.2017.01740","article-title":"Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets","volume":"8","author":"Farmer","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhep.2007.08.011","article-title":"Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities","volume":"48","author":"Malamut","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100882_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2249.2008.03711.x","article-title":"Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia","volume":"153","author":"Ward","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib31","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10875-013-9873-6","article-title":"Nodular regenerative hyperplasia in common variable immunodeficiency","volume":"33","author":"Fuss","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.dld.2018.01.132","article-title":"Natural history of patients with non cirrhotic portal hypertension: comparison with patients with compensated cirrhosis","volume":"50","author":"Gioia","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100882_bib33","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic portal hypertension: natural history and long-term outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100882_bib34","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.jaip.2019.04.016","article-title":"Liver disease is common in patients with common variable immunodeficiency and predicts mortality in the presence of cirrhosis or portal hypertension","volume":"7","author":"Azzu","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jhepr.2023.100882_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100882_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100882_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13023-015-0288-8","article-title":"Idiopathic non-cirrhotic portal hypertension: a review","volume":"10","author":"Schouten","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhepr.2023.100882_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-018-2331-3","article-title":"Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts","volume":"473","author":"Valla","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jhepr.2023.100882_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.21258","article-title":"Nodular regenerative hyperplasia: not all nodules are created equal","volume":"44","author":"Reshamwala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100882_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120299","article-title":"Diagnosing nodular regenerative hyperplasia of the liver is thwarted by low interobserver agreement","volume":"10","author":"Jharap","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2023.100882_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cld.459","article-title":"Noncirrhotic portal hypertension: pathology and nomenclature","volume":"5","author":"Kleiner","year":"2015","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jhepr.2023.100882_bib42","doi-asserted-by":"crossref","first-page":"152833","DOI":"10.1016\/j.prp.2020.152833","article-title":"Nodular regenerative hyperplasia - an under-recognized vascular disorder of liver","volume":"216","author":"Bakshi","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jhepr.2023.100882_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jhep.2010.07.038","article-title":"Obliterative portal venopathy: portal hypertension is not always present at diagnosis","volume":"54","author":"Cazals-Hatem","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100882_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100882_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1078\/0344-0338-5710012","article-title":"Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver","volume":"197","author":"Nakanuma","year":"2001","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jhepr.2023.100882_bib46","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.humpath.2004.06.016","article-title":"Intrasinusoidal cytotoxic CD8+ T cells in nodular regenerative hyperplasia of the liver","volume":"35","author":"Ziol","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhepr.2023.100882_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jhepr.2023.100882_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2023.100882_bib50","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2023.100882_bib51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2023.100882_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.744606","article-title":"Gut dysbiosis and intestinal barrier dysfunction: potential explanation for early-onset colorectal cancer","volume":"11","author":"Ahmad Kendong","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jhepr.2023.100882_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12929-018-0483-8","article-title":"Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis","volume":"25","author":"Yu","year":"2018","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.jhepr.2023.100882_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1128\/iai.23.2.403-411.1979","article-title":"Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model","volume":"23","author":"Berg","year":"1979","journal-title":"Infect Immun"},{"key":"10.1016\/j.jhepr.2023.100882_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1521-6918(03)00024-6","article-title":"Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut","volume":"17","author":"Wiest","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100882_bib56","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/694629","article-title":"Microbial translocation in chronic liver diseases","volume":"2012","author":"Pinzone","year":"2012","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.jhepr.2023.100882_bib57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100882_bib58","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the intestinal microbiome and gut barrier to hepatic disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100882_bib59","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/gerona\/gls178","article-title":"Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults","volume":"67","author":"Stehle","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jhepr.2023.100882_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.iac.2018.08.006","article-title":"Gastrointestinal manifestations and complications of primary immunodeficiency disorders","volume":"39","author":"Agarwal","year":"2019","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jhepr.2023.100882_bib61","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.dld.2019.05.016","article-title":"Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency","volume":"51","author":"Crescenzi","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100882_bib62","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/mi.2016.18","article-title":"Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation","volume":"9","author":"Jorgensen","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10875-021-01104-5","article-title":"Bowel histology of CVID patients reveals distinct patterns of mucosal inflammation","volume":"42","author":"van Schewick","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib64","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100882_bib65","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhepr.2023.100882_bib66","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/jclinpath-2012-201046","article-title":"CVID patients with autoimmunity have elevated T cell expression of granzyme B and HLA-DR and reduced levels of Treg cells","volume":"66","author":"Carter","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jhepr.2023.100882_bib67","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000547","article-title":"Autoimmune hepatitis in a patient with common variable immunodeficiency","volume":"8","author":"Myneedu","year":"2021","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.jhepr.2023.100882_bib68","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000467","article-title":"Autoimmune hepatitis in a patient with common variable immunodeficiency","volume":"7","author":"Pollock","year":"2020","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.jhepr.2023.100882_bib69","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/gut.2003.036806","article-title":"Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody","volume":"53","author":"Austin","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100882_bib70","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"European Association for the Study of the","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100882_bib71","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s10875-022-01319-0","article-title":"Evaluation of laboratory and sonographic parameters for detection of portal hypertension in patients with common variable immunodeficiency","volume":"42","author":"Globig","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100882_bib72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jhep.2022.03.024","article-title":"Faculty. Corrigendum to \u2018Baveno VII - renewing consensus in portal hypertension\u2019 [J Hepatol (2022) 959-974]","volume":"77","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100882_bib73","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00535-012-0703-z","article-title":"Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography","volume":"48","author":"Furuichi","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100882_bib74","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017961","article-title":"Spleen stiffness measurements using point shear wave elastography detects noncirrhotic portal hypertension in human immunodeficiency virus","volume":"98","author":"Ahmad","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhepr.2023.100882_bib75","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jhep.2022.05.033","article-title":"Porto-sinusoidal vascular disorder","volume":"77","author":"De Gottardi","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100882_bib76","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1148\/radiol.12111785","article-title":"Obliterative portal venopathy: findings at CT imaging","volume":"263","author":"Glatard","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.jhepr.2023.100882_bib77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11882-009-0051-0","article-title":"Autoimmunity in common variable immunodeficiency","volume":"9","author":"Agarwal","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jhepr.2023.100882_bib78","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cgh.2013.02.024","article-title":"Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency","volume":"11","author":"Agarwal","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100882_bib79","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/apt.12490","article-title":"Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy","volume":"38","author":"Musumba","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100882_bib80","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1136\/gut.2006.114363","article-title":"Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine","volume":"56","author":"Vernier-Massouille","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100882_bib81","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ibd.21330","article-title":"Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine","volume":"17","author":"Seksik","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhepr.2023.100882_bib82","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/lt.20554","article-title":"Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity","volume":"11","author":"de Boer","year":"2005","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jhepr.2023.100882_bib83","doi-asserted-by":"crossref","first-page":"100038","DOI":"10.1016\/j.liver.2021.100038","article-title":"Challenges in liver transplantation for common variable immunodeficiency-related liver disease: a case series and systematic review","volume":"4","author":"Tranah","year":"2021","journal-title":"J Liver Transplant"},{"key":"10.1016\/j.jhepr.2023.100882_bib84","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/liv.12360","article-title":"Beta-blockers in portal hypertension: new developments and controversies","volume":"34","author":"Tripathi","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100882_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010902","article-title":"Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis","volume":"6","author":"Li","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2023.100882_bib86","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.510300124","article-title":"Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis","volume":"30","author":"Banares","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100882_bib87","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1007\/s10620-005-2877-1","article-title":"Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate\/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients","volume":"50","author":"Sarin","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2023.100882_bib88","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/j.gastro.2010.06.017","article-title":"Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension","volume":"139","author":"Sarin","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100882_bib89","article-title":"Beta-blockers in cirrhosis: evidence-based indications and limitations","volume":"2","author":"Rodrigues","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100882_bib90","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2021.07.018","article-title":"North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension","volume":"20","author":"Boike","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100882_bib91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11739-019-02252-8","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes","volume":"15","author":"Vizzutti","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jhepr.2023.100882_bib92","article-title":"Where does TIPS fit in the management of patients with cirrhosis?","volume":"2","author":"Garcia-Pagan","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100882_bib93","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/j.jaip.2021.02.056","article-title":"International multicenter experience of transjugular intrahepatic portosystemic shunt implantation in patients with common variable immunodeficiency","volume":"9","author":"Globig","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jhepr.2023.100882_bib94","doi-asserted-by":"crossref","DOI":"10.5001\/omj.2020.64","article-title":"Infectious complications reporting in common variable immunodeficiency: a systematic review and meta-analysis","volume":"35","author":"Zainaldain","year":"2020","journal-title":"Oman Med J"},{"key":"10.1016\/j.jhepr.2023.100882_bib95","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.28547","article-title":"Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension","volume":"64","author":"Bissonnette","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100882_bib96","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/apt.13809","article-title":"Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS)","volume":"44","author":"Bettinger","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100882_bib97","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100882_bib98","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/cc11381","article-title":"Clinical review: the liver in sepsis","volume":"16","author":"Nesseler","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.jhepr.2023.100882_bib99","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/lt.24979","article-title":"Liver transplantation in adults with liver disease due to common variable immunodeficiency leads to early recurrent disease and poor outcome","volume":"24","author":"Azzu","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2023.100882_bib100","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/TP.0000000000004444","article-title":"Liver transplantation for porto-sinusoidal vascular liver disorder: long-term outcome","volume":"107","author":"Magaz","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100882_bib101","doi-asserted-by":"crossref","first-page":"66","DOI":"10.6002\/ect.2022.0067","article-title":"Good long-term outcome following liver transplant in a patient with common variable immunodeficiency syndrome despite multiple infections and recurrent nodular regenerative hyperplasia","volume":"21","author":"Bonatti","year":"2023","journal-title":"Exp Clin Transpl"},{"key":"10.1016\/j.jhepr.2023.100882_bib102","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226095","article-title":"Successful liver transplantation in common variable immune deficiency with reversal of hepatopulmonary syndrome","volume":"12","author":"Apostolov","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jhepr.2023.100882_bib103","first-page":"256","article-title":"Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations","volume":"83","author":"Haboubi","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100882_bib104","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.1840200114","article-title":"Nodular regenerative hyperplasia of the liver graft after liver transplantation","volume":"20","author":"Gane","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100882_bib105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0034-1375963","article-title":"Drug-induced nodular regenerative hyperplasia","volume":"34","author":"Ghabril","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100882_bib106","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJM200002033420504","article-title":"Correction of the hyper-IgM syndrome after liver and bone marrow transplantation","volume":"342","author":"Hadzic","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100882_bib107","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11894-020-00792-0","article-title":"Causes and management of non-cirrhotic portal hypertension","volume":"22","author":"Gioia","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jhepr.2023.100882_bib108","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-10-6","article-title":"Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient","volume":"10","author":"Bihl","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100882_bib109","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","article-title":"Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial","volume":"136","author":"Abraldes","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100882_bib110","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.dld.2015.07.156","article-title":"Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: a randomized controlled trial","volume":"47","author":"Pollo-Flores","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100882_bib111","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","article-title":"Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis","volume":"150","author":"Abraldes","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100882_bib112","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100882_bib113","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jsfa.6356","article-title":"Bifidobacteria and humans: our special friends, from ecological to genomics perspectives","volume":"94","author":"Ventura","year":"2014","journal-title":"J\u00a0Sci Food Agric"},{"key":"10.1016\/j.jhepr.2023.100882_bib114","first-page":"1","article-title":"Is there a role for microbiome-based approach in common variable immunodeficiency?","author":"Poto","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jhepr.2023.100882_bib115","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.aad9358","article-title":"Antibiotic use and its consequences for the normal microbiome","volume":"352","author":"Blaser","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2023.100882_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060042","article-title":"Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy","volume":"8","author":"Bajaj","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2023.100882_bib117","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2011.02650.x","article-title":"Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia","volume":"32","author":"Kalambokis","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100882_bib118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41598-018-35367-7","article-title":"Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency","volume":"9","author":"Jorgensen","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100882_bib119","first-page":"23","article-title":"Gut dysbiosis and fecal microbiota transplantation in autoimmune diseases","author":"Belvoncikova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2023.100882_bib120","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1089\/aid.2022.0016","article-title":"Fecal microbiota transplantation for people living with human immunodeficiency virus: a scoping review","volume":"38","author":"Caira-Chuquineyra","year":"2022","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jhepr.2023.100882_bib121","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apt.16148","article-title":"Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020","volume":"53","author":"Marcella","year":"2021","journal-title":"Aliment Pharmacol Ther"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:34:41Z","timestamp":1762900481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":121,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2589555923002136"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100882","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of liver disease and portal hypertension in common variable immunodeficiency (CVID)","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100882"}}